OLFARO-OR Suspension

OLFARO-OR Suspension

Olfaro-OR Suspension contains Ofloxacin 50 mg, Ornidazole 125 mg and Racecadotril 15 mg. It is a prescription oral suspension formulated for the management of certain infectious diarrhoea and gastrointestinal infections, while Racecadotril helps reduce excessive intestinal fluid secretion associated with acute diarrhoea.

Olfaro-OR Suspension by Astalabs is a combination oral suspension containing Ofloxacin, Ornidazole and Racecadotril. The formulation combines antibacterial and antiprotozoal activity with an antisecretory component to provide a comprehensive approach to the management of selected cases of acute diarrhoea associated with infection.

Ofloxacin is a fluoroquinolone antibacterial agent that acts against susceptible bacteria by interfering with bacterial enzymes involved in DNA replication. Ornidazole belongs to the nitroimidazole group and provides activity against susceptible anaerobic bacteria and protozoal organisms.

Racecadotril is an intestinal antisecretory medicine that helps reduce excessive secretion of water and electrolytes into the intestine. By reducing intestinal fluid loss, it can help decrease the frequency and volume of stools in acute diarrhoea.

Olfaro-OR Suspension is supplied as a 30 ml oral suspension, making it convenient for administration when prescribed for pediatric patients. The appropriate dose should be determined by a healthcare professional based on the patient’s age, body weight, clinical condition and cause of diarrhoea.

Along with appropriate medical treatment, maintaining adequate fluid and electrolyte replacement is important in the management of diarrhoea, particularly in children.

Key Benefits

  • Combines Ofloxacin and Ornidazole for antibacterial and antiprotozoal activity against susceptible organisms.
  • Helps manage certain infectious gastrointestinal conditions when prescribed appropriately.
  • Racecadotril helps reduce excessive intestinal fluid secretion.
  • May help reduce the frequency and volume of stools in acute diarrhoea.
  • Convenient oral suspension dosage form.
  • Designed for use under medical supervision, including pediatric use when specifically prescribed.
  • Provides a combination of antimicrobial and antisecretory support in selected cases.

Indications

Olfaro-OR Suspension may be prescribed for:

  • Certain acute infectious diarrhoeal conditions
  • Suspected or confirmed bacterial gastrointestinal infections
  • Certain protozoal intestinal infections
  • Infectious gastroenteritis caused by susceptible organisms
  • Acute diarrhoea where an antimicrobial combination and antisecretory therapy are considered appropriate by a healthcare professional

Important: Antibiotics should not be used for every case of diarrhoea. Many diarrhoeal illnesses are viral and do not require antibiotics. Medical evaluation is particularly important for children, severe diarrhoea, blood in stools, persistent vomiting, high fever, or signs of dehydration.


Composition

Each 5 ml of suspension contains:

  • Ofloxacin — 50 mg
  • Ornidazole — 125 mg
  • Racecadotril — 15 mg
Business Guide*
close slider
Scroll to Top